Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MAGNETISMM-3 STUDY
M MohtyaM TomassonbB ArnulfcN BahlisdM PrinceeR NiesvizkyfP Rodrgue-OterogJ Martine-LopezhG KoehneiY JethavajA GabayankD StevenslA NookamN RajenS IidaoE LeippU ConteqA CzibereqA ViqueirarV BlunksA Lesokhint
a Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
b Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States
c Hôpital Saint-Louis, Paris, France
d Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
e Epworth Healthcare, Melbourne, Australia
f Weill Cornell Medical College – New York Presbyterian Hospital, New York, United States
g Clinica Universidad de Navarra, Madrid, Spain
h Hospital Universitario 12 DE OCTUBRE, Madrid, Spain
i Miami Cancer Institute, Miami, United States
j Indiana Blood & Marrow Transplant, Indianapolis, United States
k Beverly Hills Cancer Center, Beverly Hills, United States
l Norton Cancer Center, Louisville, United States
m Winship Cancer Institute, Atlanta, United States
n Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States
o Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
p Pfizer Inc, Cambridge, United States
q Pfizer Inc, New York, United States
r Pfizer SLU, Madrid, Spain
s Pfizer, São Paulo, Brazil
t Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States
Ver más
Lido
993
Vezes
que se leu este artigo
353
Total PDF
640
Total HTML
Compartilhar estatísticas
Informação do artigo
ISSN: 25311379
Idioma original: Inglês
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2025 6 25 14 39
2025 5 56 10 66
2025 4 37 15 52
2025 3 57 14 71
2025 2 52 20 72
2025 1 37 28 65
2024 12 28 16 44
2024 11 33 13 46
2024 10 30 18 48
2024 9 46 18 64
2024 8 39 20 59
2024 7 39 18 57
2024 6 37 21 58
2024 5 35 27 62
2024 4 42 16 58
2024 3 15 9 24
2024 2 10 13 23
2024 1 5 9 14
2023 12 6 17 23
2023 11 10 24 34
2023 10 1 13 14
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Hematology, Transfusion and Cell Therapy